National Academy of Sciences, Washington, DC 20001;
Science Journals, American Association for the Advancement of Science, Washington, DC 20005.
Proc Natl Acad Sci U S A. 2018 Mar 13;115(11):2557-2560. doi: 10.1073/pnas.1715374115. Epub 2018 Feb 27.
In keeping with the growing movement in scientific publishing toward transparency in data and methods, we propose changes to journal authorship policies and procedures to provide insight into which author is responsible for which contributions, better assurance that the list is complete, and clearly articulated standards to justify earning authorship credit. To accomplish these goals, we recommend that journals adopt common and transparent standards for authorship, outline responsibilities for corresponding authors, adopt the Contributor Roles Taxonomy (CRediT) (docs.casrai.org/CRediT) methodology for attributing contributions, include this information in article metadata, and require authors to use the ORCID persistent digital identifier (https://orcid.org). Additionally, we recommend that universities and research institutions articulate expectations about author roles and responsibilities to provide a point of common understanding for discussion of authorship across research teams. Furthermore, we propose that funding agencies adopt the ORCID identifier and accept the CRediT taxonomy. We encourage scientific societies to further authorship transparency by signing on to these recommendations and promoting them through their meetings and publications programs.
为了顺应科学出版界在数据和方法方面日益增强的透明度趋势,我们提议对期刊作者政策和程序进行修改,以深入了解哪位作者负责哪些贡献,更好地确保列表完整,并明确阐明获得作者身份的标准。为了实现这些目标,我们建议期刊采用通用和透明的作者标准,概述相应作者的责任,采用贡献归因的 Contributor Roles Taxonomy (CRediT)(docs.casrai.org/CRediT)方法,将此信息包含在文章元数据中,并要求作者使用 ORCID 持久数字标识符(https://orcid.org)。此外,我们建议大学和研究机构阐明对作者角色和责任的期望,为跨研究团队讨论作者身份提供共识点。此外,我们提议资助机构采用 ORCID 标识符并接受 CRediT 分类法。我们鼓励科学学会通过签署这些建议并通过其会议和出版计划来进一步提高作者身份的透明度。
Proc Natl Acad Sci U S A. 2018-2-27
Naunyn Schmiedebergs Arch Pharmacol. 2024-12
Swiss Med Wkly. 2015-2-21
Adv Simul (Lond). 2025-4-18
Cell Mol Life Sci. 2025-3-17
Nature. 2025-3
Sci Rep. 2024-11-28
Mol Genet Genomics. 2024-10-23
Sci Adv. 2017-11-8
J Med Ethics. 2013-8-17
Nature. 2006-7-6
Public Aff Q. 1996-10